γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

NCT04028440 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma
Chronic Lymphoblastic Leukemia
Peripheral T Cell Lymphoma

Interventions

BIOLOGICAL: Autologous γδT cells

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]
[object Object]